Chimerix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-98.26	-147.7	90.45
Depreciation & Amortization	37.39	39.62	39.66
Other Amortization	7.65	5.41	4.16
Loss (Gain) From Sale of Assets	-3.79	7.63	-3.45
Asset Writedown & Restructuring Costs	-	0.43	1.69
Stock-Based Compensation	2.99	2.3	2.73
Other Operating Activities	33.93	-3.47	0.59
Change in Accounts Receivable	-28.03	-33.64	-6.65
Change in Inventory	3.14	-37.62	-2.5
Change in Accounts Payable	6.29	31.22	-6.18
Change in Unearned Revenue	-3.56	22.58	-1.48
Change in Other Net Operating Assets	-13.29	-83.56	-1.4
Operating Cash Flow	-55.53	-196.79	117.6
Capital Expenditures	-172.86	-75.93	-55.72
Sale of Property, Plant & Equipment	123.92	64.16	17.99
Other Investing Activities	2.19	2.08	0.85
Investing Cash Flow	-46.76	-9.69	-36.88
Short-Term Debt Issued	85	-	-
Long-Term Debt Issued	393.01	105.23	286.78
Total Debt Issued	478.01	105.23	286.78
Long-Term Debt Repaid	-402.51	-144.67	-265.02
Net Debt Issued (Repaid)	75.5	-39.44	21.76
Issuance of Common Stock	-	103.75	103.76
Other Financing Activities	41.43	68.94	-99.49
Financing Cash Flow	116.92	133.25	26.03
Net Cash Flow	14.64	-73.23	106.75
Free Cash Flow	-228.39	-272.73	61.87
Free Cash Flow Margin	-19.11%	-41.13%	19.55%
Cash Interest Paid	25.57	21.4	13.44
Levered Free Cash Flow	-106.2	-227.99	-
Unlevered Free Cash Flow	-91.76	-212.4	-
Change in Net Working Capital	-57.85	102.1	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.